A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : PCa

Search Conditions:
Search Keyword : PCa
Search Method : Exact match.
Research Area:

Results:  
Hit abbr.: 3 kinds.
(Click one to see its hit entries.)

(Appearance freq, Descending)
Abbreviation: PCa
Appearance Frequency: 9548 time(s)
Long forms: 46

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
prostate cancer
(9019 times)
Neoplasms
(2864 times)
PSA (1366 times)
RP (651 times)
AR (650 times)
1983 Circadian rhythm in prostatic acid phosphatase (PAP): a potential tumor marker rhythm in prostatic cancer (PCa).
prostate carcinoma
(249 times)
Neoplasms
(78 times)
BPH (56 times)
PSA (33 times)
HGPIN (12 times)
1977 Search for oncogenic viruses in human prostate cancer.
prostate adenocarcinoma
(71 times)
Neoplasms
(22 times)
BPH (11 times)
GS (5 times)
PSA (5 times)
1985 Effect of transfer factor on tumor-associated immunity and tumor growth of the Dunning R-3327G rat prostate adenocarcinoma.
pancreatic cancer
(62 times)
Gastroenterology
(18 times)
CP (13 times)
NI (5 times)
AIP (3 times)
1998 Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay.
prostatic adenocarcinoma
(52 times)
Pathology
(20 times)
HGPIN (15 times)
PSA (11 times)
BPH (9 times)
1994 Prostate inhibin peptide (PIP) in prostate cancer: a comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP).
pancreatic carcinoma
(18 times)
Gastroenterology
(10 times)
CP (12 times)
PPJ (7 times)
IPMN (4 times)
1991 Serum ribonuclease activity in the diagnosis of pancreatic disease.
pancreatic adenocarcinoma
(10 times)
Gastroenterology
(6 times)
CP (5 times)
ACP (1 time)
asTF (1 time)
2006 Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation.
prostate cancer patients
(9 times)
Urology
(4 times)
ADT (4 times)
BMD (2 times)
RP (2 times)
1998 [Metalloproteinases (MMP-1, MMP-3) and their inhibitors (TIMP) in blood plasma of patients with prostate carcinoma].
anti-prostate cancer
(6 times)
Neoplasms
(2 times)
AI (1 time)
AR (1 time)
ART (1 time)
2013 The interactions of dietary tomato powder and soy germ on prostate carcinogenesis in the TRAMP model.
10  Parathyroid carcinoma
(6 times)
Endocrinology
(4 times)
iPTH (2 times)
ALP (1 time)
DSS (1 time)
2010 The ratio of parathyroid hormone as measured by third- and second-generation assays as a marker for parathyroid carcinoma.
11  Plasma calcium
(5 times)
Nephrology
(2 times)
CaAc (1 time)
DCa (1 time)
FCa45 (1 time)
1989 Autotransplantation of avian parathyroid glands: an animal model for studying parathyroid function.
12  prostate cancer cells
(3 times)
Neoplasms
(3 times)
BMSC (1 time)
CA (1 time)
CRPC (1 time)
2009 Fenugreek: a naturally occurring edible spice as an anticancer agent.
13  plasma Ca
(2 times)
Veterinary Medicine
(1 time)
BR (1 time)
ENa (1 time)
HM (1 time)
1988 Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate.
14  plasma ionized calcium
(2 times)
Veterinary Medicine
(1 time)
ALB (1 time)
BV (1 time)
Ca (1 time)
1994 Alterations in blood viscosity in horses competing in cross country jumping.
15  prostatic calculi and prostate cancer
(2 times)
Reproductive Medicine
(2 times)
GSs (1 time)
PSA (1 time)
TRUS (1 time)
2010 Prostate calculi in cancer and BPH in a cohort of Korean men: Presence of calculi did not correlate with cancer risk.
16  prostatic carcinogenesis and prostate cancer
(2 times)
Cell Transformation, Neoplastic
(1 time)
CNF1 (1 time)
EMT (1 time)
PSCA (1 time)
2016 Knockdown of PSCA induces EMT and decreases metastatic potentials of the human prostate cancer DU145 cells.
17  calcium propionate
(1 time)
Environmental Health
(1 time)
LAB (1 time)
SL (1 time)
2010 A ready-to-use antifungal starter culture improves the shelf life of packaged bread.
18  pancreas
(1 time)
Gastroenterology
(1 time)
GI (1 time)
IORT (1 time)
2005 Late complication in patients undergoing pancreatic resection with intraoperative radiation therapy: gastrointestinal bleeding with occlusion of the portal system.
19  parotid carcinoma
(1 time)
Radiography
(1 time)
BCA (1 time)
CT (1 time)
KD (1 time)
2013 Different histological subtypes of parotid gland tumors: CT findings and diagnostic strategy.
20  partly controlled asthma
(1 time)
Allergy and Immunology
(1 time)
ACQ (1 time)
CA (1 time)
FCa (1 time)
2015 Symptom- and fraction of exhaled nitric oxide-driven strategies for asthma control: A cluster-randomized trial in primary care.
21  pathologically confirmed as prostate cancer
(1 time)
Reproductive Medicine
(1 time)
BPH (1 time)
IPSS (1 time)
LUTS (1 time)
2013 [Application value of diagnostic TURP for patients with serum PSA abnormality].
22  pathologically organ-confined cancer of the prostate
(1 time)
Nephrology
(1 time)
RRP (1 time)
2011 Residual prostatic tumour in the surgical bed following radical prostatectomy in organ-confined prostate cancer: possible prognostic significance.
23  pathophysiological characterization of the immunological layer of cancerous
(1 time)
Biochemistry
(1 time)
BPH (1 time)
2016 The prostate cancer immunome: In silico functional analysis of antigenic proteins from microarray profiling with IgG.
24  patients with clinical or biochemical suspicion forprostate cancer
(1 time)
Diagnostic Imaging
(1 time)
CS (1 time)
2019 MRI-TRUS fusion guided prostate biopsy - initial experience and assessment of the role of contralateral lobe systematic biopsy.
25  PCa without metastasis
(1 time)
Urology
(1 time)
BPH (1 time)
PSA (1 time)
VTN (1 time)
2016 Evaluation of Vitronectin Expression in Prostate Cancer and the Clinical Significance of the Association of Vitronectin Expression with Prostate Specific Antigen in Detecting Prostate Cancer.
26  pelvic cancer treatments, specifically prostate
(1 time)
Urologic Diseases
(1 time)
FU (1 time)
RCa (1 time)
URF (1 time)
2017 Management of iatrogenic urorectal fistulae in men with pelvic cancer.
27  peripheral cancerous
(1 time)
Diagnostic Imaging
(1 time)
ADC (1 time)
ANOVA (1 time)
AUC (1 time)
2014 Diffusion-weighted signal models in healthy and cancerous peripheral prostate tissues: comparison of outcomes obtained at different b-values.
28  PET/CT diagnosis ofprostate cancer
(1 time)
Diagnostic Imaging
(1 time)
Ga-68 PSMA (1 time)
2016 Nuclear Medicine Imaging of Prostate Cancer.
29  Piper cabralanum
(1 time)
Biology
(1 time)
OSCC (1 time)
PA (1 time)
PC (1 time)
2019 Cytotoxicity and selectiveness of Brazilian Piper species towards oral carcinoma cells.
30  plasma concentrations of calcium
(1 time)
General Surgery
(1 time)
--- 1984 [Primary hyperparathyroidism. Lack of effect of cimetidine on plasma levels of parathyroid hormone and calcium].
31  plastocyanin a
(1 time)
Biochemistry
(1 time)
PC (1 time)
PCb (1 time)
pI (1 time)
1990 Microheterogeneity of parsley plastocyanin.
32  positive for cancer
(1 time)
Pathology
(1 time)
--- 2015 Heterogeneity of PTEN and ERG expression in prostate cancer on core needle biopsies: implications for cancer risk stratification and biomarker sampling.
33  pre-cachexia
(1 time)
Nutritional Sciences
(1 time)
Ca (1 time)
NCa (1 time)
RCa (1 time)
2017 Use of routinely available clinical, nutritional, and functional criteria to classify cachexia in advanced cancer patients.
34  preference factors
(1 time)
Chemistry
(1 time)
MAS (1 time)
MD (1 time)
NMR (1 time)
2015 Na/Ca Intermixing around Silicate and Phosphate Groups in Bioactive Phosphosilicate Glasses Revealed by Heteronuclear Solid-State NMR and Molecular Dynamics Simulations.
35  presence of cancer
(1 time)
Urology
(1 time)
--- 2008 Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study.
36  primary cancers after prostate cancer
(1 time)
Neoplasms
(1 time)
NPCR (1 time)
2012 Primary cancers before and after prostate cancer diagnosis.
37  promoting cancer
(1 time)
Biochemistry
(1 time)
CM (1 time)
2018 Comparative Secretome Profiling and Mutant Protein Identification in Metastatic Prostate Cancer Cells by Quantitative Mass Spectrometry-based Proteomics.
38  prostate adenocarcinoma specimens
(1 time)
Biochemistry
(1 time)
13-HODE (1 time)
1997 Production of 13-hydroxyoctadecadienoic acid (13-HODE) by prostate tumors and cell lines.
39  prostate carcinogenesis
(1 time)
Genetics
(1 time)
SPDEF (1 time)
2014 SPDEF inhibits prostate carcinogenesis by disrupting a positive feedback loop in regulation of the Foxm1 oncogene.
40  prostate development and cancer
(1 time)
Urology
(1 time)
AR (1 time)
AREs (1 time)
ARORs (1 time)
2009 Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions.
41  protein C activity
(1 time)
Neoplasms
(1 time)
5-FU (1 time)
FPA (1 time)
PSag (1 time)
1990 Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin.
42  PubMed abstracts applied to prostate
(1 time)
Medical Informatics
(1 time)
BCa (1 time)
EMU (1 time)
2011 Toward an automatic method for extracting cancer- and other disease-related point mutations from the biomedical literature.
43  pulmonary arterial compliance
(1 time)
Cardiology
(1 time)
PAH (1 time)
RHC (1 time)
2017 Prognostic relevance of pulmonary arterial compliance after therapy initiation or escalation in patients with pulmonary arterial hypertension.
44  pulmonary capillary a wave
(1 time)
Pulmonary Medicine
(1 time)
LV (1 time)
LV pre a (1 time)
PA (1 time)
1975 Assessing left ventricular filling pressure with flow-directed (Swan-Ganz) catheters. Detection of sudden changes in patients with left ventricular dysfunction.
45  pulmonary compliance
(1 time)
Cardiology
(1 time)
Cpc-PH (1 time)
DPG (1 time)
HFrEF-PH (1 time)
2018 Haemodynamic effects of an acute vasodilator challenge in heart failure patients with reduced ejection fraction and different forms of post-capillary pulmonary hypertension.
46  pulmonary vascular compliance
(1 time)
Cardiology
(1 time)
DPG (1 time)
HF (1 time)
HFpEF (1 time)
2017 Pulmonary hemodynamics in heart failure patients with reduced or preserved ejection fraction and pulmonary hypertension: Similarities and disparities.